Gastroenterology & Digestive Health
Irritable Bowel Syndrome (IBS)
IBS affects millions of people worldwide, causing abdominal discomfort, bloating, diarrhea, constipation, and changes in bowel habits. CenExel partners with sponsors to advance innovative IBS treatments through patient-focused clinical research across diverse populations.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Advancing IBS Clinical Research
CenExel provides specialized expertise in Irritable Bowel Syndrome clinical trials, combining scientific precision with patient-centered care. Our experienced research teams support studies focused on IBS-D, IBS-C, mixed IBS, gut-brain interaction disorders, and emerging gastrointestinal therapies.
Conditions Covered
IBS Conditions We Research
Our gastrointestinal research sites support a broad range of IBS-related conditions and digestive health disorders.
- IBS with Constipation (IBS-C)
- IBS with Diarrhea (IBS-D)
- Mixed IBS (IBS-M)
- Functional Abdominal Pain
- Bloating & Gas Disorders
- Chronic Constipation
- Functional Dyspepsia
- Gut-Brain Interaction Disorders
Our Approach
Why Sponsors Choose CenExel for IBS Research
CenExel combines scientific expertise, advanced recruitment strategies, and operational excellence to support IBS clinical trials from Phase I through Phase IV.
01
GI Research Expertise
Our experienced gastroenterology teams support complex IBS and digestive health studies with high-quality clinical execution.
02
Diverse Patient Access
CenExel sites recruit broad and diverse patient populations for improved enrollment performance.
03
Advanced Recruitment
Precision targeting and digital outreach help accelerate recruitment timelines for GI trials.
04
Reliable Study Delivery
Our operational teams ensure accurate data collection, compliance, and streamlined study management.
Phase Coverage
Supported IBS Trial Phases
CenExel supports early and late phase gastrointestinal research — from first-in-human studies through Phase IV post-market trials.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our IBS research capabilities include biomarker studies, patient-reported outcome assessments, gut microbiome evaluations, and long-term therapeutic monitoring.
IBS Research Task Force
CenExel supports gastrointestinal and digestive health studies with experienced investigators, centralized operations, and access to diverse patient populations across the United States.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
